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Tuberous sclerosis complex (TSC) is associated
with neurodevelopmental abnormalities, including
defects in neuronal migration. However, the alter-
ations in cell signaling mechanisms critical for migra-
tion and final positioning of neurons in TSC remain
unclear. Our detailed cellular analyses reveal that
reduced Tsc2 in newborn neurons causes abnormal-
ities in leading processes of migrating neurons,
accompanied by significantly delayed migration.
Importantly, we demonstrate that Reelin-Dab1
signaling is aberrantly regulated in TSC mouse
models and in cortical tubers from TSC patients
owing to enhanced expression of the E3 ubiquitin
ligase Cul5, a known mediator of pDab1 ubiquitina-
tion. Likewise, mTORC1 activation by Rheb overex-
pression generates similar neuronal and Reelin-
Dab1 signaling defects, and directly upregulates
Cul5 expression. Inhibition of mTORC1 by rapamycin
treatment or by reducing Cul5 largely restores
normal leading processes and positioning of
migrating neurons. Thus, disrupted Reelin-Dab1
signaling is critically involved in the neuronal migra-
tion defects of TSC.INTRODUCTION
Tuberous sclerosis complex (TSC) is an autosomal dominant
disorder characterized by brain malformations. Patients often
exhibit one or more neurological symptoms, including epilepsy,
cognitive disability, and autism (Crino et al., 2006). Cortical tu-
bers, which are consistently found in TSC patients, are directly
related to seizures (Feliciano et al., 2012; Prabhakar et al.,C2013). TSC results from mutations in TSC1 (hamartin or TSC1)
or TSC2 (tuberin or TSC2), which encodes GTPase-activating
protein (GAP) (Sancak et al., 2005). TSC1/2 inhibit the small
GTPase Rheb, an activator of mTOR kinase (Kwiatkowski and
Manning, 2005). Loss of TSC1 or TSC2 function, therefore,
causes activation of the mTOR Complex 1 (mTORC1). Inhibiting
mTORC1 with rapamycin corrects many of the pathological fea-
tures of TSC in mouse models (Carson et al., 2012; Way et al.,
2012), including laminar abnormalities, suggesting that aberrant
activation of mTORC1 signaling plays a major role in TSC
pathophysiology. However, the primary signaling cascade by
which activated mTORC1 alters neuronal migration and position
is not well understood.
During cortical neurogenesis, newly generated postmitotic
neurons initially have a multipolar shape but soon become bipo-
lar with a leading process directed toward the pia and a trailing
process directed ventrally (Nadarajah et al., 2003). Early-born
neurons migrate to their final position by glia-independent somal
translocation: the nucleus and cytoplasmmovewhile the leading
process remains fixed. To accomplish the normal inside-out
pattern of cortical layering, late-born neurons must navigate
long distances and bypass earlier born neurons. The leading pro-
cess of a late-born neuron follows a course that is guided by glia
until it reaches the marginal zone (MZ). Final positioning then oc-
curs by somal translocation (Nadarajah et al., 2003). Among the
many identified signaling pathways that modulate neuronal
migration, Reelin-Dab1 signaling is a pivotal and well-defined
pathway that regulates migration by translating extracellular
cues into cytoskeletal changes (Fo¨rster et al., 2010; Frotscher,
2010).
Reelin is a large glycoprotein secreted predominantly byCajal-
Retzius (CR) cells in the MZ during cortical neurogenesis. It reg-
ulates migration of newborn neurons by promoting neuronal po-
larity, mediating interactions with glia, and stabilizing leading
processes for somal translocation (Britto et al., 2011; Dulabon
et al., 2000; Franco et al., 2011; Sanada et al., 2004; Sekine
et al., 2011). Reelin signals through the Vldlr and ApoER2ell Reports 12, 965–978, August 11, 2015 ª2015 The Authors 965
receptors to their cytoplasmic adaptor protein Dab1, which is
phosphorylated by Src family tyrosine kinases (Arnaud et al.,
2003; D’Arcangelo et al., 1999). Phosphorylated Dab1 (pDab1)
plays a central role in neuronal migration by activating down-
stream effectors, such as Crk, C3G, Rap1, and PI3K (Ballif
et al., 2004; Honda et al., 2011; Jossin and Goffinet, 2007;
Park and Curran, 2008; Sekine et al., 2012), and is subject to
multiple types of regulation, including ubiquitin E3 ligase Cul5-
mediated degradation (Feng et al., 2007).
Our genetic, cellular, and molecular analyses of Tsc2 condi-
tional knockout (CKO) and knockdown (KD) mice provide
evidence that Tsc2 exerts a critical function in cortical laminar or-
ganization and MZ maintenance. Remarkably, we have found
that the levels of both Reelin and Dab1 are significantly elevated
in human cortical tubers and in the forebrain-specific Tsc2 CKO
mice. However, pDab1, a central component of Reelin signaling,
is reduced due to aberrantly increased expression of the up-
stream regulator Cul5. Inhibiting mTORC1 activity restores
pDab1 and Cul5 levels to normal. The reduction of Cul5 abro-
gates migration defects resulting from Tsc2 KD or Rheb overex-
pression, providing evidence that Cul5 is a molecular link that
mediates crosstalk between mTOR- and Reelin-Dab1-signaling
pathways in TSC pathogenesis.
RESULTS
Tsc2-Deficient Neurons Have Migration Defects and
Invade the MZ
To understand the molecular and cellular mechanisms underly-
ing neuropathological features of TSC, we generated a
cortical-specific CKO of Tsc2 using Emx1-Cre mice. This CKO
expresses Cre in cortical progenitors on embryonic day (E)9.5
(Gorski et al., 2002), and reduced Tsc2 protein levels were de-
tected as early as E12.5 (Figure S1A). By postnatal day (P)0, an
increase in cortical thickness was apparent in the Tsc2 CKO
mice (Tsc2flox/flox;Emx1-Cre mice) compared to wild-type (WT)
control littermates, similar to other known Tsc2 or Tsc1mutants
with cortical deletion. However, in accordance with previous re-
ports of Tsc1 or Tsc2 mutants using other Cre drivers, such as
hGFAP or Synapsin, the increased cortical size of Tsc2 CKO
was not due to a significant increase in the number of neurons
(Figure 1D; data not shown). Instead, the increased cortical
thickness occurred because the somata of neurons were
enlarged. This is demonstrated by comparing the soma size of
Cux1+ late-born neurons (outlined by N-cadherin, Figure S1B)
in the Tsc2 CKO to WT. This result indicates the critical role of
TSC-mTOR in cell growth as opposed to proliferation in gener-
ating cortical hyperplasia.
Tsc2 CKOmice exhibited neuronal migration defects, such as
a split of hippocampal CA1 and 2 regions into defined layers,
diminished MZ, and less organized layers of the cerebral cortex
(Figure 1A). Similar defects also were observed in Tsc2flox/flox;
Nestin-Cre mice and Tsc2flox/flox;hGFAP-Cre mice (data not
shown) (Way et al., 2009). The lamination defects in Tsc2 CKO
were further investigated using layer-specific markers, including
Cux1 (layers 2–4), FoxP1 (layers 3–5), and FoxP2 (layer 6) at P24.
We found that a significant number of Cux1+ upper-layer neu-
rons were displaced into the deeper cortex or infiltrated the966 Cell Reports 12, 965–978, August 11, 2015 ª2015 The AuthorsMZ, although the total number of these cells was largely un-
changed (Figure 1B). FoxP1+ neurons also failed to show their
normal, tightly restricted distribution, and ectopic FoxP1+ neu-
rons were present in layer 2 and the MZ (Figure 1C). We also
found fewer and less tightly organized FoxP2+ neurons at P24
(Figure S1C). Overall, the absence of Tsc2 was associated with
a diffuse distribution of neurons from all layers and excessive
upper-layer neurons in the MZ.
To better understand the basis of the lamination defects, we
determined the positions of neurons at P0 using layer-specific
markers and pCAG-GFP labeling at E15.5 via in utero electropo-
ration. Compared to WT, fewer Cux1+ neurons were positioned
in the normal upper layers (2–4) and more were distributed in
deeper layers of the cortex in Tsc2 CKO (Figure 1D), suggesting
delayed and/or defective migration in Tsc2 CKO. Layer 5-spe-
cific Ctip2+ neurons also were spread more broadly in the
Tsc2 CKO than in WT (Figure 1E). Similarly, more migrating neu-
rons labeled at E15.5 and E16.5 by pCAG-GFP electroporation
were consistently positioned in deeper layers in the Tsc2 CKO
at P0 than in WT (Figures 1F and S1E, respectively). Additional
analysis of the migratory behavior by tracking birth-dated post-
mitotic cells with high BrdU content (injected at E16.5 and
analyzed at P1) confirmed the delay in migration of Tsc2-
deficient late-born neurons (Figure S1F). BrdU+ neurons in the
intermediate zone (IZ) or lower cortical plate overlapped with
Cux1, but not with Ctip2, indicating their fate as late-born
neurons.
To determine whether ectopic neurons at P0 can be posi-
tioned correctly at later stages, the distribution of Cux1+ neu-
rons at P7 was examined (Figure S1D). Although a substantial
number of ectopic Cux1+ neurons were found in deeper layers,
a reduced proportion of neurons was observed in the lower
bins, especially bins 6–10, suggesting some catch-up of
neuronal migration. Interestingly, the number of Cux1+ neurons
in bin 1, which covers mainly the MZ, was clearly increased,
indicating a progressive increase of late-born neurons in the
MZ over time. Tsc2flox/flox;Nestin-Cre animals showed similar
migration defects and lamination abnormalities (Figures S1G
and S1H).
Next, we examined the morphology of Tsc2-deficient migrat-
ing neurons by tracing the processes of GFP-labeled neurons
whose leading process contacted the MZ in 3D images taken
from 100-mm-thick sections (Figure 1G). We found a significantly
increased number of Tsc2-deficient neurons displayed elon-
gated and simplified leading processes compared to WT.
Approximately 60% of Tsc2-deficient neurons had less than
three branches and an average leading process length of
60 mm, whereas 36% of WT neurons had less than three
branches and the average leading process length was 26 mm
(Figures 1H and 1I). Although the trailing processes of migrating
neurons appeared to be longer in some Tsc2 CKO neurons, this
was not observed consistently (data not shown). Thus, leading
process defects are potentially responsible for the delayed
migration and abnormal positioning of neurons observed in
Tsc2-deficient cortices. Possible mechanisms include hindering
interactions with radial glia processes or impairing somal trans-
location, for which establishment of a stable, adhesive, and com-
plex leading process is required (Gil-Sanz et al., 2013).
Figure 1. Abnormal Neuronal Migration Causes Lamination Defects in Tsc2-Deficient Cortex and Hippocampus
(A) Histology of WT and Tsc2 CKO mice at P17 shows reduced thickness of the MZ (arrow), and Ctip2 immunostaining reveals disorganization of hippocampal
layers at P24.
(B) Cux1+ late-born neurons are excessive in the MZ (arrows) and ectopically localized in the deep cortical layers of Tsc2 CKO mice at P24.
(C) FoxP1+ neurons are widely dispersed and present in layer 2 (bracket) and the MZ in Tsc2 CKO at P24 (arrows).
(D) Cortex was divided into 10 bins and the percentage of Cux1+ neurons was quantified at P0. Graph shows total numbers of Cux1+ cells.
(E) Ctip2+ layer 5 neurons show wider distribution in Tsc2 CKO.
(F) Defective migration of Tsc2 CKO neurons at P0, visualized by in utero electroporation with pCAG-GFP at E15.5, is shown.
(G–I) Leading processes of CKO neurons contacting the MZ are longer with fewer branches thanWT neurons. Graph depicts percentage with three to five or one
to two branches (40 neurons from three WT animals, 40 neurons from three CKO animals). Data are presented as mean ± SD. *p < 0.0001 by Student’s t test.
Scale bar represents 100 mm (A, top, B, and C), 200 mm (A, bottom), 40 mm (D–F), and 20 mm (G). See also Figure S1.
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Reelin-Dab1 Signaling Is Impaired in Tsc2 CKO
Reelin-Dab1 signaling is critical for maintaining the integrity of
the MZ (Kubo et al., 2010), and migration defects in TSC mice
models resemble the phenotype of the hypomorphic allele of
Dab1, in which infiltration of late-born neurons to MZ, retarded
neuronal migration, and distinct hippocampal layering defects
were reported (Herrick and Cooper, 2002). Therefore, we
reasoned that impaired Reelin-Dab1 signaling might be respon-
sible for the migration defects observed in Tsc2 CKO cortices.
To test this possibility, the levels of Reelin-Dab1 signaling mole-
cules were examined in the developing cortices at P0 and E16.5,
when Tsc2 is largely absent, in conjunction withmTORC1 activa-
tion (Figures 2A and S1A). Elevated mTORC1 signaling activity
was observed by phosphorylation of S6 (pS6) at Ser 240/244
and found in most cortical plate neurons at P0 (Figure 2B),
E16.5, E18.5, and P24 (Figures S2A, S2D, and S2B) in the
CKOs, while mTORC1 activity was mainly limited to a subset
of neurons, including subplate and layer 5 neurons, in WT. Inter-
estingly, immunostaining and western blot analysis consistently
showed that both Reelin and Dab1 proteins were increased in
the Tsc2 CKO compared to WT cortices (Figures 2C–2E, S2C,
and S2E). However, RT-PCR analyses showed no change in
Reelin or Dab1 at the transcription level (Figure 2F), suggesting
abnormal posttranslational regulation in the absence of Tsc2.
Previous studies have established the importance of Dab1
phosphorylation upon activation of Reelin signaling and ubiqui-
tin-mediated downregulation of pDab1 during neuronal migra-
tion (Arnaud et al., 2003; Feng et al., 2007). When Reelin
signaling is impaired, pDab1 level is concomitantly reduced
while total Dab1 protein increases, thus eliciting defective
neuronal migration (Arnaud et al., 2003; Bock et al., 2004). In
Tsc2 CKO, the level of pDab1 was significantly reduced at
E16.5 and P0, whereas total Dab1 was increased (Figure 2G),
consistent with the notion that impaired Reelin-Dab1 signaling
might be an underlying mechanism in Tsc2-deficient cortex.
To gain further evidence of Reelin-Dab1 signaling defects
linked to Tsc2 pathology, Purkinje cell (PC) migration during
cerebellar development was examined by eliminating Tsc2 in
the PCs using Nestin Cre mice. Reelin-Dab1 signaling plays a
critical role in PC migration (Gallagher et al., 1998; Perez-Garcia
et al., 2004; Yang et al., 2002). Reelin is expressed in postmitotic
granule cells, and Reelin receptors and Dab1 are expressed in
the PCs, mediating the upward migration of PCs to form the
PC plate beneath the external granule cell layer (Goffinet et al.,
1999). Because PCs are a major source of Shh, a mitogen for
cerebellar granule cell precursors (Wechsler-Reya and Scott,
1999), PC migration defects in Reelin signaling mutants cause
cerebellar hypoplasia, which is also consistently found in human
patients with mutant Reelin (Hong et al., 2000). Our analysis of
the Tsc2flox/flox;Nestin Cre, which deletes Tsc2 in the progenitors
of PCs and other cerebellar cells, revealed PC migration defects
and a smaller cerebellum with a reduced number of folia (Fig-
ure 2H). At P5, when Tsc2 expression was almost completely
eliminated in the cerebellum of Tsc2flox/flox;Nestin Cre mice,
Calbindin+ PCs were ectopically localized in the deeper layer
of cerebellar plate (arrows). Concomitantly, Dab1 expression in
the PCs was clearly increased, especially in the ectopic PC
found in the deeper layer of Tsc2flox/flox;Nestin Cre animals968 Cell Reports 12, 965–978, August 11, 2015 ª2015 The Authorscompared to WT littermates (Figure 2I). At E17.5, an increase
in Dab1 levels also was observed in the Tsc2flox/flox;Nestin Cre
posterior cerebellum (Figure 2I) where PC defects were most
prominent, although Reelin levels were not obviously different
from the WT (Figure 2I).
Because Tsc2flox/flox;Nestin Cre animals cannot survive
beyond P5, it is not feasible to investigate defects in granule
cells, which migrate downward along Bergmann glia fibers to
form the internal granule cell layer during the second postnatal
week (Hatten and Mason, 1990; Solecki et al., 2006). To deter-
mine whether migration defects are specific to PCs or global,
we investigated migration defects in Tsc2flox/flox;hGFAP Cre, in
which Cre recombination occurs in the majority of progenitors,
but not in the progenitors of early-born neurons, including PCs.
We found that, although the cerebellum was enlarged and
granule cell size appeared to be increased (data not shown),
there were no obvious migration/positioning defects of granule
neurons, evidence against the idea that abnormal regulation of
mTOR signaling causes global migration defects.
Cul5 Expression Is Abnormally Regulated in the
Tsc2 CKO
To determine whether the reduction of pDab1 resulted from
changes in the level and the activity of Fyn, which directly phos-
phorylates Dab1, we examined expression of Fyn in the Tsc2-
deficient cortex. Fyn expression was significantly reduced in
the cortical plate as well as in the IZ of the Tsc2 CKO compared
to WT (Figure 3A). The total protein and phosphorylated Fyn also
were reduced substantially in cortical lysates from the Tsc2CKO
(Figures 3E–3H). Next we examined the level of total and phos-
phorylated Src family kinase (SFK), since Src also is known to
phosphorylate Dab1 during cortical neuron migration. Western
blot analysis of SFK and pSFK suggested that total SFK was
slightly increased while pSFK was clearly increased in the Tsc2
CKO (Figures 3E, 3F, and S3C). Because pSFK is widely distrib-
uted in the developing cortex, we performed immunohistochem-
ical analysis to determine the cell types with increased pSFK
(Figures 3B and S3A). Although pSFK was elevated in both the
ventricular zone (VZ) and the subventricular zone (SVZ) of the
Tsc2 CKO, the pSFK level in the cortical plate was much lower
than that ofWT (Figure 3C). These results suggest that the reduc-
tion of Fyn and activated SFK in the cortical platemay be respon-
sible for decreased pDab1 in migrating neurons.
Because Cullin 5 (Cul5), a core component of E3 ubiquitin-
protein ligase complexes, is involved in the ubiquitin-mediated
degradation of pSrc kinase (Laszlo and Cooper, 2009), Fyn
(Simo´ and Cooper, 2013), and pDab1 (Feng et al., 2007), the
reduction of pSFK, Fyn, and pDab1 in the cortical plate may
have resulted from increased expression of E3 ubiquitin ligase
Cul5 in Tsc2-deficient neurons. To determine the involvement of
Cul5 in Tsc2 pathology, we conducted immunostaining andwest-
ern blot analyses and found a prominent increase of Cul5 in the
Tsc2 CKO mouse brain (Figures 3D–3F, S3B, and S3C). At P0,
there was slightly more Cul5 in the cortical plates of WT than in
the VZ (Figure 3D). In the Tsc2 CKOs, however, Cul5 expression
was concentrated in the upper portion of the cortical plate and
in CR cells, where pS6 expression was enriched. This result pro-
vides evidence for abnormal Cul5 upregulation in Tsc2-deficient
Figure 2. Reelin-Dab1-Signaling Pathway Is Perturbed in Tsc2 CKO
(A and B) Tsc2 immunohistochemistry shows downregulated Tsc2 expression but increased pS6 expression in most regions of Tsc2 CKO cortex as compared
to WT.
(C) Dab1 is widely distributed in the cortex at P0 in both WT and Tsc2 CKO but markedly increased in CKO.
(D) Western blots for Reelin and Dab1 from Tsc2 CKO cortical extracts show highly increased protein levels at both E16.5 and P0, respectively.
(E) Dab1 expression relative to GAPDH was quantified by ImageJ.
(F) Transcription levels of Reelin and Dab1 are not changed when determined by RT-PCR.
(G) Level of pDab1 was decreased in Tsc2 CKO at E16 and P0.
(H) In Tsc2flox/flox;Nestin-Cre, Tsc2 expression is undetectable in cerebellum at P5, whereas intense Tsc2 staining is found in the PC layer of WT. Calbindin+ PCs
are positioned aberrantly in the deeper areas, as is most evident in the posterior lobes (enlarged picture).
(I) Dab1 expression in PCs is limited to the PC layer in the WT (arrows), whereas intense Dab1 staining is found in ectopic Calbindin+ PCs (arrows) in addition to
those in the PC layer in CKO. At E17.5, strong Dab1expression (red) is detected in the posterior PC plates in CKO (arrows) compared to WT.
Scale bar represents 200 mm (A and C, left), 100 mm (B, left, H, and I), 40 mm (C, enlarged), and 20 mm (B, enlarged). Data are presented asmean ± SD. *p < 0.05 by
Student’s t test. See also Figure S2.
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Figure 3. Cul5 Expression Is Abnormally Upregulated in the Absence of Tsc2
(A) The level of Fyn is reduced in the Tsc2 CKO.
(B) Intense pSFK expression in the VZ and SVZ, but cortical pSFK expression at P0 is lower in the Tsc2 CKO than WT.
(C) Immunostained images imported into ImageJ were deconvolved to further confirm distribution patterns of pSFK expression by measuring fluorescence
intensity per pixel across the cortex.
(D) Immunostaining of Cul5 in the cortex of WT and Tsc2CKO demonstrates focal increase of Cul5 expression in the upper layer of cortical plate in the Tsc2 CKO
as compared to WT. CR cells are visualized by Cul5 and pS6 expression in both WT and Tsc2 CKO; expression is increased in Tsc2 CKO.
(E and F) Western blot analysis shows more abundant pSFK and Cul5 protein, but reduced Fyn and pFyn expression, in the Tsc2 CKO in comparison to WT.
(G and H) Level of pFyn is decreased in CKO.
(I and J) Higher Cul5 mRNA level in CKO than in WT, determined by RT-PCR and qPCR. CP, cortical plate; VZ, ventricular zone; SVZ, subventricular zone; IZ,
intermediate zone.
Scale bar represents 200 mm (A, left), 40 mm (A, right, B, and D, left), and 20 mm (D, enlarged). Data are presented as mean ± SD. *p < 0.05 by Student’s t test. See
also Figure S3.neurons, includingCRcells. RT-PCRandqPCRanalyses demon-
strated that the elevation of Cul5 in the Tsc2 CKO was partly due
to transcriptional upregulation, as Cul5 transcripts were 5-fold
higher than in WT at P0 (Figures 3I and 3J). Together, increased
expression of Cul5 may be responsible for pDab1 reduction
through excessive degradation aswell as inefficient phosphoryla-
tionbydiminishingpFynandpSFK, resulting in the increased total
Dab1 that was consistently observed in the Tsc2 CKO.
Reelin-Dab1 Signaling Is Disrupted in Cortical Tubers
To determine whether Reelin-Dab1 signaling is perturbed in TSC
patients, we next examined levels of Reelin-Dab1 signaling pro-
teins in cortical tuber sections. Tubers are focal malformations
in the TSC cortex that lack laminar structure. They contain
enlarged, dysmorphic neurons and numerous glia cells as well
as undifferentiated Nestin+ progenitor-like (giant) cells that
exhibit biallelic loss of TSC1 or TSC2 (Crino et al., 1996, 2010).
Tubers can be found as early as 19 weeks gestation and likely
form as a consequence of abnormal neuronal migration. Addi-970 Cell Reports 12, 965–978, August 11, 2015 ª2015 The Authorstionally, giant cells and dysmorphic neurons retain embryonic
cellular and molecular characteristics (Maldonado et al., 2003).
Therefore, we considered that tubers might provide a unique
system for observing developmental defects, including altered
Reelin-Dab1 signaling, at later stages.
Accordingly, areas with normal laminar morphology immedi-
ately adjacent to tubers failed to show a distinctive immunopos-
itive signal of Reelin, Dab1, or Cul5 (Figure 4A). We never
observed abnormal expression of Reelin-Dab1 signaling mole-
cules in the Tsc2 heterozygote cortices at P0, supporting the
idea that full deletion of Tsc2 is required for abnormal regulation
of Reelin-Dab1 signaling (Figure S3D). Immunostaining of
cortical tubers in three cases consistently revealed intense
Dab1, Reelin, and Cul5 expression in the giant cells (Figures
4A and 4B). We also observed elevated Reelin expression in
two subependymal giant cell astrocytoma (SEGA) samples and
in an additional cortical tuber sample, demonstrating wide-
spread upregulation of Reelin expression in TSC cases (Figures
S4A–S4D). To ensure the specificity of immune detection of
Figure 4. Expression of Reelin-Dab1-Signaling Proteins Is Altered in Human TSC Tubers
(A) Control human cortex and non-tuber region of TSC patient cortex show very low Reelin, Dab1, and Cul5 expression.
(B) Reelin, Dab1, and Cul5 are highly expressed in giant cells (GCs) in the tuber and some also are expressed in astrocytes (smaller cells) in three independent
cases of cortical tubers.
Scale bar represents 50 mm. See also Figure S4.Reelin and Dab1 in the cortical tuber sections, we confirmed
that, as expected, they were distinctly expressed in the embry-
onic human brain as a positive control (Figure S4F). Human
embryonic cortices at 19 weeks also showed enriched Cul5
expression in the top of the cortical plate, analogous to the
mouse cortex at P0. (Figure S4E). Collectively, these findings
support the hypothesis that, as in the Tsc2 CKO mice, Reelin-
Dab1 signaling is disturbed in human cortical tubers, suggesting
a potential contribution to TSC pathogenesis.
Prenatal Treatment with Rapamycin Rescues Migration
and Reduces the Expression of Dab1 and Cul5
To obtain direct evidence that the Reelin-Dab1 signaling and
cellular defects in Tsc2-deficient neurons were the result of the
abnormal mTORC1 activation, we treated Tsc2 CKO mice with
rapamycin, a well-established mTORC1 inhibitor. Rapamycin
previously was reported to rescue lamination defects in
the hippocampus and cortex when administered prenatally to
Tsc2flox/flox;hGFAP-Cre mice (Carson et al., 2012). Consistent
with the prediction, the number of neurons with delayed migra-
tion was significantly reduced and lamination defects were no
longer detectable at P0 when rapamycin was administered dur-
ing embryogenesis (E13.5–P0) (Figures S5A–S5H). Rapamycin
treatment reverted the levels of pDab1 and Dab1 in the Tsc2
CKO to normal and also restored Fyn expression (Figures 5A–
5C). These results suggest that mTORC1 is an upstream regu-
lator of pDab1 and that neuronal migration caused by abnormal
Reelin-Dab1 signaling is mediated by mTOR activity.
Next, we assessed whether rapamycin treatment reduces
Cul5 mRNA and protein expression. Cul5 protein expression in
rapamycin-treated Tsc2 CKO cortical sections and extracts
was indistinguishable from that of WT littermates. Interestingly,Crapamycin effectively reduced expression of Cul5 protein in
Tsc2 CKO, but not in WT, as compared to vehicle-treated ani-
mals (Figures 5B and 5C). However, rapamycin treatment signif-
icantly reduced Cul5 mRNA expression in both WT and Tsc2
CKO mice, although the degree of reduction was more promi-
nent in the Tsc2CKO (Figure 5D). Thus, our results withmTORC1
inhibition establish that aberrant regulation of pDab1, Fyn, and
Cul5 resulted from mTORC1 hyperactivation.
Cul5 Reduction Rescues the Migration Defects of Tsc2
KD Neurons
To determine whether Cul5 overexpression is directly respon-
sible for the cellular phenotypes and neuronal migration defects
underlying the Tsc2 CKO, we manipulated Cul5 and Tsc2
expression levels with small hairpin RNA (shRNA). Examination
of Cul5 and Tsc2 protein levels in electroporated cortical lysates
confirmed the efficacy ofCul5 and Tsc2 shRNA (Figures S6A and
S6B). We first determined the degree of migration delay caused
by Tsc2 KD. We used in utero electroporation to introduce Tsc2
shRNA (Tsai et al., 2012) or control scrambled shRNA along with
pCAG-GFP to cortical progenitors at E13.5 and E16.5, and we
analyzed the position of GFP+ neurons 5 days later (Figures
S6C and 6A). Similar to the delayed migration in Tsc2 CKO
shown in Figure 1F, significantly fewer Tsc2 KD late-born neu-
rons reached the top of the cortex compared to control (Fig-
ure 6A). Tsc2 KD neurons were distributed broadly in the cortical
wall and moderately enriched in the deeper layers of the cortex
and IZ (bins 4–7). We also compared the migration defects of
Tsc2 KD neurons with those of neurons overexpressing the 5F
Dab1 phosphorylation-defective mutant protein in which five
tyrosine (Tyr185, 198, 200, 220, and 232) residues are switched
to phenylalanine (Howell et al., 2000). Themigration defects wereell Reports 12, 965–978, August 11, 2015 ª2015 The Authors 971
Figure 5. Rescue of Tsc2-Mediated Migra-
tion Defects by Inhibition of mTOR
(A and B) Rapamycin treatment (E13.5–P0) de-
creases Dab1 and Cul5 expression in Tsc2 CKO.
(C) Western blot analysis of Tsc2 CKO and WT at
P0 after rapamycin treatment demonstrates the
restoration of expression levels of Dab1, pDab1,
and Cul5. Expression levels of Dab1, Cul5, and Fyn
relative to GAPDH was quantified by ImageJ.
(D) Decreased level of Cul5 transcripts in both WT
and Tsc2 CKO after rapamycin treatment is shown
by RT-PCR and qPCR.
Scale bar represents 40 mm (A and B). Data are
presented as mean ± SD. *p < 0.05 by Student’s
t test. See also Figure S5.similar to that of Tsc2CKO (Figure 1F): very few neurons of either
type reached the upper layers (bins 2–3) and most remained
in the deeper layers and IZ (Figures 6A and 6B). However, the
migration delay was considerably greater when 5F was overex-
pressed, consistent with the idea that partial reduction, but not
complete absence, of pDab1 is likely responsible for the migra-
tion defect in Tsc2 CKO. Because Tsc2 CKO neurons showed
simplified leading processes at P0 (Figures 1G–1I), we traced
the leading processes of Tsc2 shRNA-expressing migrating
neurons contacting the MZ at P2 (electroporated at E16.5) (Fig-
ure 6C). Similar to Tsc2 CKO, the leading processes of Tsc2 KD
neurons were longer and less branched than those of the control
shRNA-electroporated neurons (Figures 6D and 6E), supporting
the notion that Tsc2 mutation exerts its effects in a cell-autono-
mous manner.
Next, we attempted to rescue Tsc2 KD phenotypes by
reducing the Cul5 level with Cul5 shRNA. Cul5 KD neurons
mainly accumulated in the top of the cortical plate and only rarely
appeared in deeper layers of cortex (Figures 6A and 6B), consis-
tent with a previous observation (Simo´ et al., 2010). Importantly,
Cul5 KD almost completely rescued the migration defects of
Tsc2 KD neurons and restored normal migration and distribution
(Figures 6A, 6B, and S6C) Furthermore, the leading processes
of double-shRNA-treated neurons recovered the complexity of
their branches and their shorter length (30 mm), comparable
to that of control shRNA (31 mm) (Figures 6C–6E). Remarkably,
Cul5 KD also rescued the migration defects of Tsc2 CKO when972 Cell Reports 12, 965–978, August 11, 2015 ª2015 The AuthorsCul5 shRNA was electroporated at E15.5
and the position of neurons examined at
P0 (Figure 6F). Together, our results with
Cul5 manipulations suggest that migra-
tion delay and leading process defects
of Tsc2-deficient neurons result from up-
regulated Cul5 expression.
Rheb Overexpression Causes
Neuronal Migration Delay and
Impairment of Reelin-Dab1
Signaling through Upregulation of
Cul5 Expression
To further establish the role of mTOR
signaling in the regulation of Cul5 expres-sion, we activated mTOR by overexpressing Rheb, an mTOR
activator and small GTPase enriched in brain. Enriched forced
expression of Rheb is achieved using the CAG promoter, which
elicits increased pS6 expression in H293 cells (data not shown)
and cortical explants (Figures 7B and S7C). Rheb was in utero
electroporated at E13.5, E14.5, and E16.5, and the positions
of neurons were determined 5 days later (Figures 7A, S7A, and
S7B). Rheb overexpression under all conditions examined
caused a certain degree of neuronal migration delay. Interest-
ingly, the experimental condition of E13.5 electroporation and
E18.5 harvest showed the most striking migration delay, similar
to Tsc2 KD, as the majority of neurons remained in the lower
portion of the cortical plate and IZ (Figures 7A and S6C). This
phenotype is almost completely rescued by the Cul5 KD,
supporting the role of abnormal Cul5 upregulation in neuronal
migration delay or arrest.
To determine changes in Reelin-Dab1 signaling due to Rheb
overexpression, Dab1 levels were monitored in protein lysates
from electroporated cortical areas at P0 or P2 after inducing
Rheb overexpression at E14.5 or E16.5, respectively (Figures
7B and S7C). As expected, Dab1 protein levels were increased
upon Rheb overexpression, but reduced by Cul5 KD, despite
continued aberrant mTORC1 activation as determined by pS6
expression (Figure 7B). RT-PCR and qPCR analyses demon-
strated that forced Rheb expression could increase Cul5
mRNA in the cortical explant (Figures 7C and 7D). Increased
Cul5 transcription also was achieved through overexpression
Figure 6. Rescue of Migration Defects of Tsc2 KD Neurons by Reduction of Cul5
(A) Tsc2 and Cul5 shRNA constructs, control shRNA (Scrambled), and non-phosphorylatable Dab1 (5F) constructs were electroporated at E16.5.
(B) Neuronal migration defects were analyzed at P2 by quantifying the percentage of GFP+ neurons in each bin.
(C–E) Tsc2 KD neurons have elongated and less branched leading processes compared to control shRNA-expressing neurons. Cul5 shRNA rescues the leading
process phenotype of Tsc2 KD neurons (Tsc2 shRNA, n = 32 from three cortices; Scrambled, n = 31 from three cortices; Cul5;Tsc2 double shRNA, n = 31 from
three cortices.) Data are presented as mean ± SD. *p < 0.0001 by Student’s t test.
(F) Scrambled shRNA control or Cul5 shRNA was electroporated to WT or Tsc2 CKO cortices at E15.5. Delayed migration of Tsc2 CKO neurons was rescued by
Cul5 shRNA at P0. CP, cortical plate; SVZ, subventricular zone; IZ, intermediate zone.
Scale bar represents 40 mm (A and F) and 20 mm (C). See also Figure S6.of Rheb in N2a, a mouse neuroblastoma cell line, providing
further evidence that mTOR activation can upregulate Cul5
expression in other cellular contexts (Figure 7E). Interestingly,
the expression level of Socs7, an adaptor protein that links phos-
phoryated substrates to the Cul5 E3 ubiquitin ligase complex,
was not significantly changed by either Rheb overexpression
or Tsc2 CKO (Figures 7C–7F). Furthermore, Rheb overexpres-
sion did not significantly alter Dab1 and Reelin mRNA expres-
sion, supporting the specific transcriptional regulation of Cul5
by mTOR activation. Together, mTOR activation by downregu-
lated Tsc2 or upregulated Rheb can delay cortical neuronal
migration at least partially through impaired Reelin-Dab1
signaling caused by increased Cul5 expression.
DISCUSSION
We provide evidence that impaired Reelin-Dab1 signaling plays
an important role in the pathogenesis of aberrant neuronalCmigration and positioning in TSC. Although we found that
Reelin-Dab1 signaling is impaired in Tsc2 CKO mice, the Tsc2-
deficient brain did not exhibit the typical Reelin-Dab1 mutant
phenotype of inverted cortical layers and cerebellar hypoplasia
(Howell et al., 1997; Rice et al., 1998; Sheldon et al., 1997). It is
therefore likely that Tsc2 deficiency causes a reduction, but
not a complete loss, of Reelin-Dab1 signaling. This interpretation
is consistent with the results of several previous reports. First, a
hypomorphic allele ofDab1mutant showed disturbances of spe-
cific aspects of migration, such as infiltration of MZ by late-born
cortical neurons and split of the CA1 region into two well-defined
layers (Herrick and Cooper, 2002), a phenotype remarkably
similar to that of the Tsc2 CKOmice. Second, mice null for a sin-
gle type of high-affinity Reelin receptor, Vldlr, showed excessive
pyramidal neurons in the MZ, but not preplate splitting deficits,
whereas mice double null for both high-affinity Reelin receptors,
Vldlr and ApoER2, showed the same phenotype as Reelin
or Dab1 mutants (Beffert et al., 2006). Third, ectopic Reelinell Reports 12, 965–978, August 11, 2015 ª2015 The Authors 973
Figure 7. Rheb Overexpression Impairs
Neuronal Migration and Reelin Dab1
Signaling by Enhancing Cul5 Expression
(A) pCAG-Rheb is electroporated with scrambled
shRNA control or along with Cul5 shRNA at E13,
and the position of electroporated neurons was
analyzed at E18.5 by quantifying the percentage of
GFP+ neurons in each bin.
(B) Western blot analyses of pCAG-Rheb-electro-
porated cortical areas reveal increased Cul5
and Dab1 protein levels compared to control
construct-electroporated areas. The protein levels
of Dab1 and Cul5 are substantially reduced by
concurrent expression of shCul5 and Rheb in spite
of the unchanged level of pS6. For each blot,
protein samples ran on the same gel were re-
arranged for side-by-side comparison.
(C–E) Transcription levels of Dab1, Reelin, Cul5,
and Socs7 are compared in Rheb-electroporated
versus control vector-electroporated cortices
(C and D) and N2a cells (E) by qPCR and RT-PCR.
(F) The level of Socs7 transcripts in the Tsc2 CKO
is similar to that of WT at P0. Scale bar represents
40 mm. Data are presented asmean ±SD. *p < 0.05
by Student’s t test.
See also Figure S7.expression driven by the nestin promoter in Reelin mutant mice
restored preplate splitting, but not neuronal positioning (Magda-
leno et al., 2002). This last finding provides further support for the
notion that the strength and location of Reelin-Dab1 signaling
causes the differential phenotypic outcomes largely in an activ-
ity-dependent manner. Thus, it appears that delayed neuronal
migration and infiltration of MZ are sensitive pathologic indica-
tors of ineffective Reelin-Dab1 signaling.
Abnormal neuronal migration is often found in pediatric neuro-
logical disorders with intractable epilepsy and intellectual
disability (Guerrini and Parrini, 2010; Verrotti et al., 2010). Our
studies have established the molecular link between two critical
signaling pathways that are essential for neuronal migration and
increase our understanding of the cellular and molecular mech-
anisms responsible for the abnormal neuronal migration funda-
mental to TSC pathogenesis. Several lines of evidence support
a direct pathogenic role of migration defects in the cortical mal-
formations found in TSC patients. First, lamination defects have
been reported in Tsc1 and 2 mutant mouse models (Carson
et al., 2012; Way et al., 2009). Second, Tsc1 deletion from974 Cell Reports 12, 965–978, August 11, 2015 ª2015 The Authorscortical progenitor cells caused migration
defects that led to white matter heteroto-
pias, and Tsc1 deletion from SVZ stem
cells caused migration defects that led
to subependymal nodules (Feliciano
et al., 2011, 2012; Zhou et al., 2011).
Third, our results clearly demonstrated
ectopically positioned PCs and reduced
size of the cerebellum at P5 in the Tsc2
CKO. Patients with the RELN (homolog
of Reelin) mutation suffer from epilepsy
and severe brain malformations, includinglissencephaly and cerebellar hypoplasia (Chang et al., 2007;
Hong et al., 2000; Ross et al., 2001) Furthermore, mutations of
Reelin-Dab1 signaling components or of Rbx2, which encodes
subunit of CUL5 E3 ligase complex, cause PC migration defects
(Simo´ and Cooper, 2013). Interestingly, Tsc2 loss does not
disrupt migration of cerebellar granule neurons along radial glia
processes, supporting the specificity of mTOR pathway-depen-
dent neuronal migration defects due to abnormal Reelin-Dab1
signaling.
Our results demonstrated abnormally increased expression
of Reelin in both human patients and mouse models, which
also may contribute to the retarded migration and dispersed
laminar structure observed. Reelin exerts its effects on
neuronal migration and dendritic process development by acti-
vating mTOR through the upregulation of AKT and PI3K (Jossin
and Goffinet, 2007). This suggests that mTOR activation is
required for neuronal migration and that during neuronal
migration mTOR may participate in a feedback mechanism to
regulate Cul5 expression and finely adjust the pDab1 level. A
recent study also revealed a connection between an upstream
regulator of mTOR signaling components, the Stk25-Lkb1-
strada complex, and Reelin-Dab1 signaling (Matsuki et al.,
2010). Stk25, an adaptor protein that links the polarity proteins
Lkb1 and Strada to Golgi protein GM130, can modulate Reelin-
Dab1 signaling antagonistically during the establishment of
neuronal polarity and deployment of the Golgi complex in den-
drites of hippocampal neurons (Matsuki et al., 2010). Lkb1 is an
upstream inhibitory regulator of mTOR that acts by promoting
AMP kinase (AMPK)-dependent Tsc2 phosphorylation and is
essential to generate neuronal polarity (Barnes et al., 2007;
Corradetti et al., 2004; Shaw et al., 2004). AMPK activation in
cortical neuronal culture under conditions of metabolic stress
reduces mTORC1 signaling through phosphorylation of Tsc2
(Williams et al., 2011). Thus, further studies on the interaction
of Reelin-Dab1 and mTOR may find more emerging points
directing a common mechanism responsible for neuropatho-
logical outcomes of mTORopathies, a group of disorders re-
sulting from mTOR-mediated neurodevelopmental defects
(Crino, 2011).
Our results demonstrating that rapamycin restores Reelin-
Dab1 signaling activity in the Tsc2 CKO and that reducing
Cul5 rescues migration defects of Tsc2 KD neurons have impor-
tant therapeutic potential for neuronal migration disorders due
to perturbations of the Reelin-Dab1- and mTOR-signaling
pathways. This evidence is consistent with the idea that impair-
ments in Reelin-Dab1 signaling may contribute to the neuropa-
thology and neurological manifestations in Pretzel syndrome
and phosphatase tensin homolog (PTEN)-related diseases,
such as Cowden syndrome (Nelen et al., 1999), and with the
expectation that at least some of these abnormalities may
respond to rapamycin. Pretzel syndrome is associated with
deletion of the Strada gene (Parker et al., 2013). Knockdown
of Strada in developing mouse cortex by in utero electroporation
produces neuronal migration delay, which is analogous to Tsc2
deficiency, and mTORC1 activation is observed in fibroblast cell
lines derived from patients and in the cortex of individuals with
this disease (Parker et al., 2013). It is, therefore, extremely inter-
esting that treatment with rapamycin prevents seizures in infants
with this syndrome. Intriguingly, the neuron-specific PTEN
mutant mouse, which models PTEN-related diseases, also
shows increased Dab1 protein level and lamination defects
(Kazdoba et al., 2012). Because abnormal regulation of mTOR
and Reelin-Dab1 signaling is implicated in autism and schizo-
phrenia (Beffert et al., 2006; Iafrati et al., 2014), the effects of
perturbations of the critical interplay between these signaling
pathways may extend beyond neuronal migration and include
alterations of dendrite elaboration, spine development, and syn-
aptic plasticity. Whether any of these alterations will also
respond to rapamycin or other interventions targeting mTOR
or Reelin-Dab1 signaling is speculative, but the approach may
eventually provide an effective therapy for a subset of neurode-
velopmental disorders.
In summary, our study demonstrates abnormal regulation
of Reelin-Dab1 signaling activity in the Tsc2 CKO cortex and
describes previously unappreciated molecular pathogenic
mechanisms that contribute to aberrant neuronal migration.
Furthermore, abnormal expression patterns of Reelin-Dab1
signaling genes, including the putative factor Cul5 and regula-Ctory proteins like SFK (including Fyn), are found in both Tsc2
CKO mice and human patients. These similarities provide
additional support for our hypothesis that disordered regula-




Human patient samples were obtained and treated according to the guidelines
of the Institutional Review Board of Temple University School of Medicine.
Human patient samples carrying TSC2 mutations and tubers samples were
isolated from frontal cortex.
Mice
All the animal experiments were performed in accordance with the guidelines
of the Institutional Animal Care and Use Committees of Temple University
School of Medicine. Tsc2flox/flox mice (Hernandez et al., 2007) were bred to
Emx1-Cre (Jackson Laboratory 005628) or Nestin-Cre (Jackson Laboratory
003771) mice to generate conditional Tsc2 knockout mice.
Co-immunoprecipitation
Cell lysates from PBS- or rapamycin- treated cerebral cortex were incubated
overnight with phosphotyrosine antibody and protein G-Sepharose beads (GE
Healthcare). Beads were washed extensively with lysis buffer and denatured
in SDS sample buffer; samples were examined by western blot with Dab1
antibody.
RNA Isolation and RT-PCR
Total RNA was extracted from cerebral cortex using TRIzol reagent (Invitro-
gen), and reverse transcription reactions were performed with total RNA;
sequence information for primers is in the Supplemental Experimental
Procedures.
Cul5 shRNA and Rheb Plasmid Generation
Cul5 shRNA construct was generated using the shRNA sequence (Feng et al.,
2007) that is effective in cortical neurons (5ʹ-GCTGCAGACTGAATTAGTAG-3ʹ)
and cloned in pLentiLox3.7 lentivirus vector that includes a dual promoter
and eGFP (Rubinson et al., 2003). The Rheb-GFP was PCR amplified with
the primer set 5ʹ-CCTCAGTCCAAGTCCCG-3ʹ (forward) and 5ʹ-TCACATCACC
GAGCACGAAGA-3ʹ (reverse) using pBk-cmv-mGFP plasmid. For full-length
Rheb expression vector, PCR product was further cloned into the pCAG
vector.
Rapamycin Treatment
Rapamycin was initially dissolved in sterile DMSO to a final concentration of
10 mM. Prior to use, this stock was diluted with PBS and injected intraperito-
neally at 0.3 mg/kg daily to pregnant females from E13.5.
In Utero Electroporation
GFP expression plasmid (1 mg/ml) and/or shRNA plasmid and scrambled
shRNA (2 mg/ml) were electroporated into embryos as previously described
(Olson et al., 2006).
Immunohistochemistry
Paraffin sections (7 mm) were prepared and immunohistochemistry was per-
formed as described previously (Cho et al., 2012). Primary antibody informa-
tion can be found in the Supplemental Experimental Procedures.
Quantitative Analyses
The z stack images encompassing 100 mm were taken with a confocal micro-
scope (Leica, SP8) every 2 mm. Details of leading process analyses and count-
ing of Cux1- and GFP-expressing cells are described in the Supplemental
Experimental Procedures. We analyzed three nonconsecutive sections taken
from 3–5 WT- or CKO-electroporated mice. For leading process analyses,
we analyzed 30–40 neurons from three well-electroporated mice for eachell Reports 12, 965–978, August 11, 2015 ª2015 The Authors 975
condition. Student’s t test was applied to assess statistical significance;
p < 0.05 was regarded as statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.07.013.
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